+7 495 109 8808 
+7 985 908 5818 info@re.gth.gd.gth.rug.com
Pharegis LLC / ООО "Фареджис"
-
-
Business address:
3-1 Begovaya str. ("NordStar Tower", 31st fl.), Moscow, Russia 125284
Legal & postal address:
11A-11 Cherkizovskaya B. str., Moscow, Russia 107392
D-U-N-S: 362071645
-
- +7 495 109 8808
-
- +7 985 908 5818 (WhatsApp)
- https://regdrug.com
Pharma Regulatory News
Feed - News and features
-
EC's von der Leyen loses bid to stop disclosure of Pfizer texts
Ursula von der Leyen has lost a...
-
Novo makes fresh obesity play with $2.2bn Septerna deal
A new licensing deal with Septerna...
-
GSK pays $1.2bn for liver drug as it culls TIGIT programme
GSK decided to abandon a...
-
Call goes out for feedback on US health deregulation
The Trump administration wants the...
News | PharmaTimes
- Herantis Pharma doses final cohort in phase 1b trial of HER-096 for Parkinson’s disease
- Kaerus Bioscience secures orphan drug designation for fragile x syndrome treatment
- Rein Therapeutics initiates renew phase 2 trial for IPF treatment
- Apiary invests in life sciences marketing specialist performance-io
- Amgen’s Tepezza granted marketing authorisation in the UK
ClinicalTrials.gov News
Feed not found.